Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study (Q46276281)
Jump to navigation
Jump to search
scientific article published in October 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study |
scientific article published in October 2008 |
Statements
1 reference
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study (English)
1 reference
Ludwig Kappos
1 reference
Ralf Gold
1 reference
David H Miller
1 reference
David G Macmanus
1 reference
Eva Havrdova
1 reference
Volker Limmroth
1 reference
Chris H Polman
1 reference
Klaus Schmierer
1 reference
Tarek A Yousry
1 reference
Minhua Yang
1 reference
Mefkûre Eraksoy
1 reference
Eva Meluzinova
1 reference
Ivan Rektor
1 reference
Katherine T Dawson
1 reference
Alfred W Sandrock
1 reference
Gilmore N O'Neill
1 reference
BG-12 Phase IIb Study Investigators
1 reference
1 October 2008
1 reference
1 reference
372
1 reference
9648
1 reference
1463-1472
1 reference
Identifiers
1 reference
1 reference